§992. Education and research
A. The Louisiana Board of Pharmacy is authorized to carry out educational programs
designed to prevent and deter misuse and abuse of controlled dangerous substances. In
connection with such programs it is authorized to:
(1) Promote better recognition of the problems of misuse and abuse of controlled
dangerous substances within the regulated industry and among interested groups and
organizations.
(2) Assist the regulated industry and interested groups and organizations in
contributing to the reduction of misuse and abuse of controlled dangerous substances.
(3) Consult with interested groups and organizations to aid them in solving
administrative and organizational problems.
(4) Evaluate procedures, projects, techniques, and controls conducted or proposed
as part of educational programs on misuse and abuse of controlled dangerous substances.
(5) Disseminate to the industry and the general public the results of research on
misuse and abuse of controlled dangerous substances to promote a better public
understanding of what problems exist and what can be done to combat them.
(6) Assist in the education and training of state and local law enforcement officials
in their efforts to control misuse and abuse of controlled dangerous substances.
B. The Louisiana Board of Pharmacy is authorized to encourage research on misuse
and abuse of controlled dangerous substances. In connection with such research and in
furtherance of the enforcement of this Part, it is authorized to:
(1) Establish methods to assess accurately the effects of controlled dangerous
substances and to identify and characterize controlled dangerous substances with potential
for abuse.
(2) Make studies and undertake programs of research to:
(a) Develop new or improved approaches, techniques, systems, equipment and
devices to strengthen the enforcement of this Part.
(b) Determine patterns of misuse and abuse of controlled dangerous substances and
the social effects thereof.
(c) Improve methods for preventing, predicting, understanding and dealing with the
misuse and abuse of controlled dangerous substances.
(3) Enter into contracts with public agencies or institutions of higher education, for
the purpose of conducting research, demonstrations, or special projects which bear directly
on misuse and abuse of controlled dangerous substances.
C. The Louisiana Board of Pharmacy may authorize persons engaged in research on
the use and effects of dangerous substances to withhold the names and other identifying
characteristics of persons who are the subjects of such research. Persons who obtain this
authorization shall not be compelled in any civil, criminal, administrative, legislative, or
other proceeding to identify the subjects of research for which authorization was obtained.
D. The Louisiana Board of Pharmacy may authorize the possession and distribution
of controlled dangerous substances by persons engaged in research in accordance with rules
promulgated by the department. Persons who obtained this authorization shall be exempt
from state prosecution for possession and distribution of dangerous substances to the extent
authorized by the Louisiana Board of Pharmacy.
E. The Louisiana Board of Pharmacy, with the concurrence and under the
supervision and control of the chief law enforcement officer of the jurisdiction wherein the
program is conducted, may authorize the possession and exhibition for educational purposes
only of controlled dangerous substances by persons employed by local and state law
enforcement agencies engaged in educational programs in accordance with rules promulgated
by the Louisiana Board of Pharmacy. Persons acting pursuant to this authorization shall be
exempt from state and local prosecution for the possession and distribution of dangerous
substances to the extent authorized by the Louisiana Board of Pharmacy. The Louisiana
Board of Pharmacy shall coordinate and evaluate the training programs of the various law
enforcement agencies to ensure compliance with the rules promulgated regulating the
possession and exhibition of controlled dangerous substances for educational purposes.
Added by Acts 1972, No. 634, §1. Amended by Acts 1978, No. 786, §5, eff. July 17,
1978; Acts 1984, No. 218, §1; Acts 2006, No. 834, §1; Acts 2018, No. 206, §4.